Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

Additional Resources

Review the current role of PSA biomarkers, strategies for increasing specificity of PSA testing, and expert advise for optimizing risk assessment protocols.

Learn how the Serum HER-2/neu Test can indicate whether metastatic breast cancer is progressing or responding to treatment.